Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A
暂无分享,去创建一个
T. Foster | D. Cox | M. Brennan | R. Downer | J. Higgins | J. Fitzgerald | A. Loughman | Anthony Loughman
[1] L. Visai,et al. FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. , 2005, Blood.
[2] J. Patti. A humanized monoclonal antibody targeting Staphylococcus aureus. , 2004, Vaccine.
[3] Barry S. Coller,et al. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics , 2004, Nature.
[4] J. Vernachio,et al. Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in an Experimental Model of Infective Endocarditis , 2003, Antimicrobial Agents and Chemotherapy.
[5] Magnus Hook,et al. A “dock, lock, and latch” Structural Model for a Staphylococcal Adhesin Binding to Fibrinogen , 2003, Cell.
[6] M. Byrne,et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. , 2003, Gastroenterology.
[7] S. Jackson,et al. Intercellular calcium communication regulates platelet aggregation and thrombus growth , 2003, The Journal of cell biology.
[8] Livia Visai,et al. Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. , 2003, Microbiology.
[9] Sheila,et al. Response of Human Platelets to Activating Monoclonal Antibodies : Importance of FcyRII ( CD 32 ) Phenotype and Level of Expression , 2003 .
[10] M. Carson,et al. A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen‐binding MSCRAMM, clumping factor A , 2002, The EMBO journal.
[11] Z. Ruggeri,et al. Induction of platelet thrombi by bacteria and antibodies. , 2002, Blood.
[12] D. Ferguson,et al. Functional Blocking of Staphylococcus aureus Adhesins following Growth in Ex Vivo Media , 2002, Infection and Immunity.
[13] N. Day,et al. Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus , 2002, Infection and Immunity.
[14] M. Byrne,et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. , 2002, Blood.
[15] D. Fitzgerald,et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A , 2002, Molecular microbiology.
[16] T. Foster,et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. , 2001, The Journal of infectious diseases.
[17] P. François,et al. Reassessing the Role of Staphylococcus aureus Clumping Factor and Fibronectin-Binding Protein by Expression in Lactococcus lactis , 2001, Infection and Immunity.
[18] T. Foster,et al. The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. , 2001, Microbiology.
[19] S. Mazmanian,et al. Sortase‐catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus , 2001, Molecular microbiology.
[20] J J Sixma,et al. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. , 2000, Blood.
[21] U. Kralisz,et al. Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. , 2000, Thrombosis research.
[22] B. Chong,et al. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. , 2000, Blood.
[23] T. Foster,et al. Surface protein adhesins of Staphylococcus aureus. , 1998, Trends in microbiology.
[24] P. François,et al. Clumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus , 1998, Molecular microbiology.
[25] J. Vermylen,et al. Recurrent arterial thrombosis linked to autoimmune antibodies enhancing von Willebrand factor binding to platelets and inducing Fc gamma RII receptor-mediated platelet activation. , 1998, Blood.
[26] T. Foster,et al. The Fibrinogen-binding MSCRAMM (Clumping Factor) ofStaphylococcus aureus Has a Ca2+-dependent Inhibitory Site* , 1998, The Journal of Biological Chemistry.
[27] P. François,et al. The dipeptide repeat region of the fibrinogen‐binding protein (clumping factor) is required for functional expression of the fibrinogen‐binding domain on the Staphylococcus aureus cell surface , 1997, Molecular microbiology.
[28] L. McIntire,et al. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. , 1997, European journal of biochemistry.
[29] I. Ford,et al. The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis , 1997, British journal of haematology.
[30] W. Foss,et al. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis , 1996, Infection and immunity.
[31] W. D. de Vos,et al. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin , 1996, Applied and environmental microbiology.
[32] I. Ford,et al. Evidence for the involvement of complement proteins in platelet aggregation by Streptococcus sanguis NCTC 7863 , 1996, British journal of haematology.
[33] P. François,et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis , 1995, Infection and immunity.
[34] P. François,et al. Identification of the ligand‐binding domain of the surface‐located fibrinogen receptor (clumping factor) of Staphylococcus aureus , 1995, Molecular microbiology.
[35] P. François,et al. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus , 1994, Molecular microbiology.
[36] W. D. de Vos,et al. Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. , 1993, European journal of biochemistry.
[37] J. Wells,et al. Improved cloning vectors and transformation procedure for Lactococcus lactis. , 1993, The Journal of applied bacteriology.
[38] S. Lord,et al. The Residues AGDV of Recombinant γ Chains of Human Fibrinogen Must Be Carboxy-Terminal to Support Human Platelet Aggregation , 1992, Thrombosis and Haemostasis.
[39] E. Davie,et al. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Aster,et al. Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. , 1992, Blood.
[41] M. Terpenning. Infective endocarditis. , 1992, Clinics in geriatric medicine.
[42] G. Stewart,et al. Repression and catabolite repression of the lactose operon of Staphylococcus aureus , 1990, Journal of bacteriology.
[43] F. Götz,et al. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. , 1990, FEMS microbiology letters.
[44] P. Sullam,et al. Role of immunoglobulin G in platelet aggregation by viridans group streptococci , 1988, Infection and immunity.
[45] M. O'Reilly,et al. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage , 1983, Nature.
[46] P. Henson,et al. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. , 1973, The Journal of clinical investigation.
[47] E. Asheshov. Loss of antibiotic resistance in Staphylococcus aureus resulting from growth at high temperature. , 1966, Journal of general microbiology.
[48] E. Duthie,et al. Staphylococcal coagulase; mode of action and antigenicity. , 1952, Journal of general microbiology.